# George Risk Industries, Inc.: financial statements, quarterly

RSKIA · OTC · CIK 84112 · [Technology](/sectors/technology.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/rskia.md) · [Financials](/companies/rskia/financials.md) · [Filings](/companies/rskia/filings.md) · [Insiders](/companies/rskia/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rskia/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [6,053](/filings/0001493152-24-050238.md) | [5,394](/filings/0001493152-25-010643.md) | [5,592](/filings/0001493152-24-029743.md) | [5,780](/filings/0001493152-25-013159.md) | [5,613](/filings/0001493152-25-027793.md) | [4,912](/filings/0001493152-26-010459.md) | [6,232 d](/filings/0001493152-26-036522.md) | [5,898](/filings/0001493152-26-042546.md) | [6,333](/filings/0001493152-25-027793.md) | [5,659](/filings/0001493152-26-010459.md) | [6,963 d](/filings/0001493152-26-036522.md) | [6,850](/filings/0001493152-26-042546.md) |
| Cost of revenue | $k | [2,949](/filings/0001493152-24-050238.md) | [2,734](/filings/0001493152-25-010643.md) | [2,781 d](/filings/0001641172-25-023170.md) | [2,835](/filings/0001493152-25-013159.md) | [2,899](/filings/0001493152-25-027793.md) | [2,614](/filings/0001493152-26-010459.md) | [3,279 d](/filings/0001493152-26-036522.md) | [2,875](/filings/0001493152-26-042546.md) | [3,364](/filings/0001493152-25-027793.md) | [3,092](/filings/0001493152-26-010459.md) | [3,572 d](/filings/0001493152-26-036522.md) | [3,623](/filings/0001493152-26-042546.md) |
| Gross profit | $k | [3,104](/filings/0001493152-24-050238.md) | [2,660](/filings/0001493152-25-010643.md) | [2,811 d](/filings/0001641172-25-023170.md) | [2,945](/filings/0001493152-25-013159.md) | [2,714](/filings/0001493152-25-027793.md) | [2,298](/filings/0001493152-26-010459.md) | [2,953 d](/filings/0001493152-26-036522.md) | [3,023](/filings/0001493152-26-042546.md) | [2,969](/filings/0001493152-25-027793.md) | [2,567](/filings/0001493152-26-010459.md) | [3,391 d](/filings/0001493152-26-036522.md) | [3,227](/filings/0001493152-26-042546.md) |
| Operating income | $k | [1,968](/filings/0001493152-24-050238.md) | [1,518](/filings/0001493152-25-010643.md) | [1,615](/filings/0001493152-24-029743.md) | [1,774](/filings/0001493152-25-013159.md) | [1,483](/filings/0001493152-25-027793.md) | [1,196](/filings/0001493152-26-010459.md) | [1,785 d](/filings/0001493152-26-036522.md) | [1,808](/filings/0001493152-26-042546.md) | [1,786](/filings/0001493152-25-027793.md) | [1,318](/filings/0001493152-26-010459.md) | [2,053 d](/filings/0001493152-26-036522.md) | [1,906](/filings/0001493152-26-042546.md) |
| Interest expense | $k | not reported | not reported | not reported | [1.0](/filings/0001493152-25-013159.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [(80.0)](/filings/0001493152-24-050238.md) | [1,608](/filings/0001493152-25-010643.md) | [651 d](/filings/0001641172-25-023170.md) | [944](/filings/0001493152-25-013159.md) | [438](/filings/0001493152-25-027793.md) | [654](/filings/0001493152-26-010459.md) | [(55.0) d](/filings/0001493152-26-036522.md) | [931](/filings/0001493152-26-042546.md) | [752](/filings/0001493152-25-027793.md) | [535](/filings/0001493152-26-010459.md) | [894 d](/filings/0001493152-26-036522.md) | [1,167](/filings/0001493152-26-042546.md) |
| Net income | $k | [(55.0)](/filings/0001493152-24-050238.md) | [3,239](/filings/0001493152-25-010643.md) | [2,000 d](/filings/0001641172-25-023170.md) | [2,705](/filings/0001493152-25-013159.md) | [2,215](/filings/0001493152-25-027793.md) | [1,607](/filings/0001493152-26-010459.md) | [605 d](/filings/0001493152-26-036522.md) | [3,792](/filings/0001493152-26-042546.md) | [2,343](/filings/0001493152-25-027793.md) | [2,480](/filings/0001493152-26-010459.md) | [2,773 d](/filings/0001493152-26-036522.md) | [2,192](/filings/0001493152-26-042546.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0001493152-24-050238.md) | [0.66](/filings/0001493152-25-010643.md) | not reported | [0.55](/filings/0001493152-25-013159.md) | [0.45](/filings/0001493152-25-027793.md) | [0.33](/filings/0001493152-26-010459.md) | not reported | [0.77](/filings/0001493152-26-042546.md) | [0.48](/filings/0001493152-25-027793.md) | [0.51](/filings/0001493152-26-010459.md) | not reported | [0.45](/filings/0001493152-26-042546.md) |
| Basic EPS | $ per share | [(0.01)](/filings/0001493152-24-050238.md) | [0.66](/filings/0001493152-25-010643.md) | not reported | [0.55](/filings/0001493152-25-013159.md) | [0.45](/filings/0001493152-25-027793.md) | [0.33](/filings/0001493152-26-010459.md) | not reported | [0.78](/filings/0001493152-26-042546.md) | [0.48](/filings/0001493152-25-027793.md) | [0.51](/filings/0001493152-26-010459.md) | not reported | [0.45](/filings/0001493152-26-042546.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.6](/filings/0001493152-23-044981.md) | [5.4](/filings/0001493152-24-010042.md) | [7.1](/filings/0001641172-25-023170.md) | [9.4](/filings/0001493152-24-036360.md) | [5.5](/filings/0001493152-24-050238.md) | [5.6](/filings/0001493152-25-010643.md) | [6.5](/filings/0001493152-26-036522.md) | [8.3](/filings/0001493152-25-013159.md) | [4.8](/filings/0001493152-25-027793.md) | [4.5](/filings/0001493152-26-010459.md) | [5.2](/filings/0001493152-26-042546.md) | [6.8](/filings/0001493152-26-042546.md) |
| Current assets | $m | [50.7](/filings/0001493152-23-044981.md) | [55.7](/filings/0001493152-24-010042.md) | [57.4](/filings/0001641172-25-023170.md) | [61.7](/filings/0001493152-24-036360.md) | [59.7](/filings/0001493152-24-050238.md) | [60.7](/filings/0001493152-25-010643.md) | [60.4](/filings/0001493152-26-036522.md) | [65.2](/filings/0001493152-25-013159.md) | [63.3](/filings/0001493152-25-027793.md) | [65.6](/filings/0001493152-26-010459.md) | [68.4](/filings/0001493152-26-042546.md) | [71.3](/filings/0001493152-26-042546.md) |
| Total assets | $m | [54.3](/filings/0001493152-23-044981.md) | [59.1](/filings/0001493152-24-010042.md) | [60.8](/filings/0001641172-25-023170.md) | [64.8](/filings/0001493152-24-036360.md) | [62.8](/filings/0001493152-24-050238.md) | [63.7](/filings/0001493152-25-010643.md) | [63.3](/filings/0001493152-26-036522.md) | [68.2](/filings/0001493152-25-013159.md) | [66.2](/filings/0001493152-25-027793.md) | [68.4](/filings/0001493152-26-010459.md) | [71.4](/filings/0001493152-26-042546.md) | [74.2](/filings/0001493152-26-042546.md) |
| Current liabilities | $m | [3.5](/filings/0001493152-23-044981.md) | [3.8](/filings/0001493152-24-010042.md) | [3.8](/filings/0001641172-25-023170.md) | [4.5](/filings/0001493152-24-036360.md) | [5.3](/filings/0001493152-24-050238.md) | [4.7](/filings/0001493152-25-010643.md) | [4.2](/filings/0001493152-26-036522.md) | [4.8](/filings/0001493152-25-013159.md) | [4.9](/filings/0001493152-25-027793.md) | [4.5](/filings/0001493152-26-010459.md) | [4.7](/filings/0001493152-26-042546.md) | [4.9](/filings/0001493152-26-042546.md) |
| Total liabilities | $m | [4.8](/filings/0001493152-23-044981.md) | [6.4](/filings/0001493152-24-010042.md) | [6.1](/filings/0001641172-25-023170.md) | [7.2](/filings/0001493152-24-036360.md) | [8.0](/filings/0001493152-24-050238.md) | [7.4](/filings/0001493152-25-010643.md) | [6.5](/filings/0001493152-26-036522.md) | [7.6](/filings/0001493152-25-013159.md) | [7.9](/filings/0001493152-25-027793.md) | [7.7](/filings/0001493152-26-010459.md) | [8.0](/filings/0001493152-26-042546.md) | [8.8](/filings/0001493152-26-042546.md) |
| Shareholders' equity | $m | [49.5](/filings/0001493152-25-010643.md) | [52.7](/filings/0001493152-25-010643.md) | [54.6](/filings/0001493152-26-036522.md) | [57.5](/filings/0001493152-25-027793.md) | [54.8](/filings/0001493152-26-010459.md) | [56.3](/filings/0001493152-26-010459.md) | [56.9](/filings/0001493152-26-042546.md) | [60.6](/filings/0001493152-26-042546.md) | [58.2](/filings/0001493152-26-010459.md) | [60.7](/filings/0001493152-26-010459.md) | [63.4](/filings/0001493152-26-042546.md) | [65.4](/filings/0001493152-26-042546.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q4 FY2024 (2024-04-30) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [587 d](/filings/0001493152-24-050238.md) | [2,427 d](/filings/0001493152-25-010643.md) | [2,020 d](/filings/0001641172-25-023170.md) | [2,295](/filings/0001493152-25-013159.md) | [230 d](/filings/0001493152-25-027793.md) | [649 d](/filings/0001493152-26-010459.md) | [1,133 d](/filings/0001493152-26-036522.md) | [2,139](/filings/0001493152-26-042546.md) | [1,189 d](/filings/0001493152-25-027793.md) | [253 d](/filings/0001493152-26-010459.md) | [1,097 d](/filings/0001493152-26-036522.md) | [1,937](/filings/0001493152-26-042546.md) |
| Capital expenditure | $k | [42.0](/filings/0001493152-24-050238.md) | [20.0](/filings/0001493152-25-010643.md) | [115](/filings/0001493152-24-029743.md) | [105](/filings/0001493152-25-013159.md) | [203](/filings/0001493152-24-050238.md) | [51.0](/filings/0001493152-25-010643.md) | [37.0 d](/filings/0001493152-26-036522.md) | [133](/filings/0001493152-26-042546.md) | [0.0 d](/filings/0001493152-25-027793.md) | [0.0 d](/filings/0001493152-26-010459.md) | [250 d](/filings/0001493152-26-036522.md) | [6.0](/filings/0001493152-26-042546.md) |
| Dividends paid | $k | [2,912 d](/filings/0001493152-24-050238.md) | [0.0 d](/filings/0001493152-25-010643.md) | [1.0 d](/filings/0001641172-25-023170.md) | not reported | not reported | [0.0 d](/filings/0001493152-26-010459.md) | [(1.0) d](/filings/0001493152-26-036522.md) | [5.0](/filings/0001493152-26-042546.md) | [4,462 d](/filings/0001493152-25-027793.md) | [0.0 d](/filings/0001493152-26-010459.md) | [0.0 d](/filings/0001493152-26-036522.md) | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2023 (2022-10-31) | Q3 FY2023 (2023-01-31) | Q1 FY2024 (2023-07-31) | Q2 FY2024 (2023-10-31) | Q3 FY2024 (2024-01-31) | Q1 FY2025 (2024-07-31) | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,951](/filings/0001493152-23-044981.md) | [4,951](/filings/0001493152-24-010042.md) | [4,949](/filings/0001493152-24-036360.md) | [4,928](/filings/0001493152-24-050238.md) | [4,920](/filings/0001493152-25-010643.md) | [4,917](/filings/0001493152-25-013159.md) | [4,917](/filings/0001493152-25-027793.md) | [4,916](/filings/0001493152-26-010459.md) | [4,913](/filings/0001493152-26-042546.md) | [4,912](/filings/0001493152-25-027793.md) | [4,910](/filings/0001493152-26-010459.md) | [4,910](/filings/0001493152-26-042546.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,888,354 at 2026-09-14, from the cover of the [10-Q filed 2026-09-14](/filings/0001493152-26-042546.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.